跳转至内容
Merck
CN

V-025

维生素D3标准液 CRM 溶液

1 mg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®

别名:

维生素D3标准液 CRM 溶液

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C27H44O
化学文摘社编号:
分子量:
384.64
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24
MDL number:
eCl@ss:
34058003
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

certified reference material

Quality Level

form

liquid

feature

(Snap-N-Shoot®), (Snap-N-Spike®)

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1 mg/mL in ethanol

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−70°C

SMILES string

O[C@H]1CCC(=C)\C(=C/C=C2/[C@H]3[C@@]([C@H](CC3)[C@@H](CCCC(C)C)C)(CCC/2)C)\C1

InChI

1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1

InChI key

QYSXJUFSXHHAJI-YRZJJWOYSA-N

Gene Information

human ... VDR(7421)

General description

维生素D3或称胆钙化醇是一种由皮肤在紫外光照射下天然形成的维生素D。维生素D3也可以工业化生产,用于强化食品或用于维生素补充剂。

Application

该认证溶液标准品适合用作Snap-N-Spike®起始材料,用于制备临床应用的校准剂或对照品,或用作Snap-N-Shoot®用于维生素补充剂、强化食品或药物制剂的质量控制测试中。

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under 维生素D3标准液 CRM 溶液


pictograms

FlameExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2

存储类别

3 - Flammable liquids

wgk

WGK 1

flash_point_f

57.2 °F

flash_point_c

14.0 °C

法规信息

危险化学品

此项目有



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

Simultaneous LC-MS/MS determination of vitamins D₂ and D₃ in infant milk powder meeting GB 5009.296-2023 criteria for accuracy and sensitivity.


Stefan Pilz et al.
Hypertension (Dallas, Tex. : 1979), 65(6), 1195-1201 (2015-03-25)
Vitamin D deficiency is a risk factor for arterial hypertension, but randomized controlled trials showed mixed effects of vitamin D supplementation on blood pressure (BP). We aimed to evaluate whether vitamin D supplementation affects 24-hour systolic ambulatory BP monitoring values
Anders Burild et al.
Steroids, 98, 72-79 (2015-03-01)
Information regarding the endogenous storages of vitamin D3 after cutaneous vitamin D synthesis compared to oral vitamin D3 supplementation is sparse. Furthermore it is not known whether vitamin D3 can be stored for later use during periods of shortages of
Robert Scragg et al.
Hypertension (Dallas, Tex. : 1979), 64(4), 725-730 (2014-07-02)
Previous randomized controlled trials of vitamin D supplementation and blood pressure (BP) mainly have given vitamin D for short periods (<6 months) or at low doses (400 IU per day). This study aims to determine whether long-term high-dose vitamin D



全球贸易项目编号

货号GTIN
V-025-1ML04061837428647